HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 2,866: | Line 2,866: | ||
|[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease||Karin Miller, MD | |[[HAEM5:Systemic chronic active EBV disease|Systemic chronic active EBV disease]]||Disease||Karin Miller, MD | ||
|3/25/2024 | |3/25/2024 | ||
| 11/17/2025||Complete | | 11/17/2025||'''Complete''' | ||
| 11/17/2025||SK|| || | | 11/17/2025||SK|| 2/14/2026|| | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|NEW (No Prior) | |NEW (No Prior) | ||
| Line 2,876: | Line 2,876: | ||
|[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||Karin Miller, MD | |[[HAEM5:Systemic EBV-positive T-cell lymphoma of childhood|Systemic EBV-positive T-cell lymphoma of childhood]]||Disease||Karin Miller, MD | ||
|3/25/2024 | |3/25/2024 | ||
| 11/17/2025||Complete | | 11/17/2025||'''Complete''' | ||
| 11/18/2025||SK|| ||prior authors not available | | 11/18/2025||SK|| ||prior authors not available | ||
|Systemic EBV-Positive T-cell Lymphoma of Childhood | |Systemic EBV-Positive T-cell Lymphoma of Childhood | ||